Global Pharmaceutical Grade Arbutin Market Strategic Research Report

Scope of the Report

The global Pharmaceutical Grade Arbutin market size is predicted to grow from US$ 153 million in 2025 to US$ 320 million in 2032; it is expected to grow at a CAGR of 11.2% from 2026 to 2032.

Pharmaceutical-grade arbutin (usually β-arbutin, CAS: 497-76-7; α-arbutin, CAS: 84380-01-8) refers to high-purity hydroquinone glucoside compounds that meet authoritative pharmaceutical standards such as the Chinese Pharmacopoeia (CP), the United States Pharmacopeia (USP), or the European Pharmacopoeia (EP). It exists in a single enantiomer form and is mainly used as a raw material or pharmaceutical excipient in pharmaceutical formulations or high-specification medical skincare products. It has a clear chemical structure, strict quality control standards, and pharmaceutical-grade safety requirements. The purity of pharmaceutical-grade arbutin is typically ≥99.5%.

The upstream core raw materials for pharmaceutical-grade arbutin include hydroquinone, glucose, catalysts, bearberry leaves (containing 6-10% arbutin by dry weight), pear bark, blueberry, recombinant enzyme (glucosyltransferase), and fermentation medium. Midstream process routes include chemical synthesis, enzymatic methods, and plant extraction methods. The downstream segment transforms pharmaceutical-grade arbutin into end products, with core applications concentrated in three major areas: dermatological drugs, medical dressings, and high-end cosmeceuticals, where extremely high requirements are placed on safety and efficacy.

In 2025, global sales of pharmaceutical-grade arbutin reached 300 tons, with a production capacity of approximately 380 tons, an average selling price of US$520/kg, and an average gross profit margin of 42%-50%.

Global key Pharmaceutical Grade Arbutin players cover DSM（NL）, Mitsubishi Chemical（JP）, ARTEC Biotechnology（CN）, HuahengBiotechnology（CN）, GfN & Selco（DE）, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Arbutin market?

What factors are driving Pharmaceutical Grade Arbutin market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Arbutin market opportunities vary by end market size?

How does Pharmaceutical Grade Arbutin break out by Type, by Application?

This report presents a comprehensive overview of the global Pharmaceutical Grade Arbutin market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity 99.0%-99.5%
• Purity 99.5%-99.9%
• Purity ≥99.9%

Segment by Chemical Configuration

• α-Arbutin
• β-Arbutin
• Deoxyarbutin

Segment by Production Processes

• Chemical Synthesis
• Bio-Enzymatic Method
• Plant Extraction Method

Segment by Application

• Dermatological Medications
• Medical Dressings
• High-End Cosmeceuticals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pharmaceutical Grade Arbutin market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Dermatological Medications, Medical Dressings, High-End Cosmeceuticals evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact